Upstream Bio Presents New Structural Data on Verekitug, Highlights Unique TSLP Receptor Targeting
Upstream Bio Inc. (NASDAQ:UPB) is one of the best hot stocks to invest in.
Upstream Bio Inc. (UPB)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 5,693,589 | $154,580,941 | 3.16% | |
| 2. | Decheng Capital Min Cui | 3,143,078 | $85,334,568 | -5% | 11.48% |
| 3. | Enavate Sciences James Boylan | 2,459,703 | $66,780,936 | 13.18% | |
| 4. | Parkman Healthcare Partners Greg Martinez | 834,559 | $22,658,277 | -2% | 2.16% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 760,252 | $20,640,842 | +27% | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 660,000 | $11,220,000.00 | 4,554,873 | 2024-10-15 | Filing | |
| $17.00 | 165,000 | $2,805,000.00 | 1,138,716 | 2024-10-15 | Filing | |
| $17.00 | 660,000 | $11,220,000.00 | 4,554,873 | 2024-10-15 | Filing | |
| $17.00 | 165,000 | $2,805,000.00 | 1,138,716 | 2024-10-15 | Filing | |
| $17.00 | 1,175,000 | $19,975,000.00 | 1,175,000 | 2024-10-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,518,202 | $204,119,193 | 0.01% | |
| 2. | 3,344,504 | $90,803,284 | 0% | |
| 3. | 2,882,647 | $78,263,866 | 0.01% | |
| 4. | 2,388,439 | $64,846,119 | 0% | |
| 5. | 1,806,243 | $49,039,498 | 0.01% |
News See All
12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
Upstream Bio, Inc. (UPB): A Bull Case Theory
We came across a bullish thesis on Upstream Bio, Inc. on Value investing subreddit by Dizzy_Drawing_2451. In this article, we will summarize the bulls’ thesis on UPB.
Upstream Bio Initiates Phase 2 Clinical Trial for COPD Drug, Verekitug
Upstream Bio Inc. (NASDAQ:UPB) is one of the best IPO stocks to buy according to Wall Street analysts.
13 Best IPO Stocks to Buy According to Wall Street Analysts
On August 14, Tony Kim, Centerview Partners co-president, joined CNBC's 'Closing Bell: Overtime' to discuss the IPO market and the dealmaking environment.
Hedge Fund Resource Center Billionaire Hedge Funds
